IP Library Granted Patent US 11,141,386
Granted Patent B1
US 11,141,386 · App. 16/282,025 · Granted Oct 12, 2021

Eye health supplement with curcumin

Inventor: James Stringham (Durham, NC)
Assignee: QH Holdings (Oregon), Inc.
A61K31/065A61K31/202A61K31/341A61K31/355A61K33/30A61K35/60A61K35/644A61K36/28A61K36/48A61K47/42A61P27/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,386
App. No.
16/282,025
Granted
Oct 12, 2021
Kind
B1
Abstract

An eye health supplement and methods of using the eye health supplement are disclosed.

Claims (29)

1. An eye health supplement dosage form, comprising:

at least 6 mg zeaxanthin;

at least 30 mg lutein;

16.75-67 mg vitamin E;

3.75-15 mg zinc;

25-100 mg curcumin; and

25-100 mg omega-3 oils providing 12.5-50 mg docosahexaenoic acid (DHA) and 12.5-50 mg eicosapentaenoic acid (EPA),

wherein the zinc is provided by zinc gluconate.

2. The eye health supplement dosage form of claim 1 , wherein the eye health supplement dosage form does not comprise resveratrol.

3. The eye health supplement dosage form of claim 1 , comprising:

1 part by weight zeaxanthin;

5 parts by weight lutein;

16.75 parts by weight vitamin E;

3.75 parts by weight zinc;

25 parts by weight curcumin; and

25 parts by weight omega-3 oils providing 12.5 parts by weight DHA and 12.5 parts by weight EPA.

4. The eye health supplement dosage form of claim 1 , further comprising fish oil, gelatin, sunflower oil, glycerin, yellow beeswax, water, carob, or any combination thereof.

5. The eye health supplement dosage form of claim 1 , wherein the lutein is present as free lutein.

6. The eye health supplement dosage form of claim 1 , wherein the dosage form is a softgel.

7. A method of supporting eye health, comprising administering to a subject a dose of an eye health supplement dosage form according to claim 1 , wherein the dose is effective to support eye health.

8. The method of claim 7 , wherein administering is performed daily.

9. The method of claim 7 , wherein the dose comprises 4 mg zeaxanthin, 20 mg lutein, 67 mg vitamin E, 15 mg zinc, 100 mg curcumin, 50 mg DHA, and 50 mg EPA.

10. The method of claim 9 , wherein the amounts are substantially equal to 4 mg zeaxanthin, 20 mg lutein, 67 mg vitamin E, 15 mg zinc, 100 mg curcumin, 50 mg DHA, and 50 mg EPA.

11. The method of claim 7 , wherein administering comprises orally administering two eye health supplement dosage forms to the subject, each eye health supplement dosage form comprising 2 mg zeaxanthin, 10 mg lutein, 33.5 mg vitamin E, 7.5 mg zinc, 50 mg curcumin, 25 mg DHA, and 25 mg EPA.

12. The method of claim 11 , wherein the amounts are substantially equal to 2 mg zeaxanthin, 10 mg lutein, 33.5 mg vitamin E, 7.5 mg zinc, 50 mg curcumin, 25 mg DHA, and 25 mg EPA.

13. The method of claim 7 , wherein the subject is exposed to blue light.

14. The method of claim 7 , wherein supporting eye health comprises supporting a healthy retina, supporting visual performance; or a combination thereof.

15. The method of claim 14 , wherein supporting a healthy retina comprises supporting a macular density of at least 0.60 over a period of time.

16. The method of claim 14 , wherein supporting visual performance comprises (i) supporting visual processing speed, (ii) supporting the ability of the subject's eyes to recover from glare, (iii) supporting contrast sensitivity, or (iv) any combination of (i), (ii), and (iii).

Assignments (2)
MERGER Recorded Oct 28, 2019
From: QUANTUM, INC.
To: QH HOLDINGS (OREGON), INC.
Reel/Frame 050844/0484 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2019
From: STRINGHAM, JAMES
To: QUANTUM, INC.
Reel/Frame 048984/0065 →
Continuity (1)
Provisional Application 62786270 · Dec 28, 2018